سعر ريفاستينج10ملجرام/5مل شراب120مل 2022
Rivastig 10 mg/5 ml syrupالفئة: مضاد للخرف
معلومات الدواء
التفاصيل الكاملةدواعي الاستعمالUses
- Symptomatic treatment of mild to moderately severe Alzheimer's dementiaالفئة: AdultsEuropean Medicines Agency
- Symptomatic treatment of mild to moderately severe dementia in patients with idiopathic Parkinson's diseaseالفئة: AdultsEuropean Medicines Agency
- Symptomatic treatment of mild to moderately severe Alzheimer's dementiaPopulation: AdultsEuropean Medicines Agency
- Symptomatic treatment of mild to moderately severe dementia in patients with idiopathic Parkinson's diseasePopulation: AdultsEuropean Medicines Agency
الآثار الجانبيةSide effects
- Most commonly reported adverse reactions are gastrointestinal, including nausea (38%) and vomiting (23%), especially during titration; women are more susceptible to GI reactions and weight loss.نشرة دولية لنفس التركيبة · European Medicines Agency
- Most commonly reported adverse reactions are gastrointestinal, including nausea (38%) and vomiting (23%), especially during titration; women are more susceptible to GI reactions and weight loss.International label, same formulation · European Medicines Agency
موانع الاستعمالContraindications
- Hypersensitivity to rivastigmine, other carbamate derivatives or any excipient.نشرة دولية لنفس التركيبة · European Medicines Agency
- Previous history of application-site reactions suggestive of allergic contact dermatitis with rivastigmine patch.نشرة دولية لنفس التركيبة · European Medicines Agency
- Hypersensitivity to rivastigmine, other carbamate derivatives or any excipient.International label, same formulation · European Medicines Agency
- Previous history of application-site reactions suggestive of allergic contact dermatitis with rivastigmine patch.International label, same formulation · European Medicines Agency
تحذيرات واحتياطاتWarnings & precautions
- QT prolongation and bradycardia (a risk factor for torsade de pointes) may occur; caution in patients with QTc prolongation risk, sick sinus syndrome or conduction defects; ECG monitoring may be required.نشرة دولية لنفس التركيبة · European Medicines Agency
- Caution in active gastric or duodenal ulcers, asthma or obstructive pulmonary disease, urinary obstruction and seizure predisposition; monitor body weight during therapy.نشرة دولية لنفس التركيبة · European Medicines Agency
- QT prolongation and bradycardia (a risk factor for torsade de pointes) may occur; caution in patients with QTc prolongation risk, sick sinus syndrome or conduction defects; ECG monitoring may be required.International label, same formulation · European Medicines Agency
- Caution in active gastric or duodenal ulcers, asthma or obstructive pulmonary disease, urinary obstruction and seizure predisposition; monitor body weight during therapy.International label, same formulation · European Medicines Agency
التداخلات الدوائيةDrug interactions
- QT-prolonging or bradycardic agents (e.g. class III antiarrhythmics, calcium channel antagonists, digitalis, some antipsychotics)Use with caution and clinical (ECG) monitoring because bradycardia is a risk factor for torsades de pointes.European Medicines Agency
- QT-prolonging or bradycardic agents (e.g. class III antiarrhythmics, calcium channel antagonists, digitalis, some antipsychotics)Use with caution and clinical (ECG) monitoring because bradycardia is a risk factor for torsades de pointes.European Medicines Agency
الحمل والرضاعةPregnancy & breastfeeding
- No clinical data on exposed pregnancies; should not be used during pregnancy unless clearly necessary.نشرة دولية لنفس التركيبة · European Medicines Agency
- Rivastigmine is excreted in animal milk; women on rivastigmine should not breast-feed.نشرة دولية لنفس التركيبة · European Medicines Agency
- No clinical data on exposed pregnancies; should not be used during pregnancy unless clearly necessary.International label, same formulation · European Medicines Agency
- Rivastigmine is excreted in animal milk; women on rivastigmine should not breast-feed.International label, same formulation · European Medicines Agency
كيف يعمل الدواءHow it works
- Reversible cholinesterase inhibitor; thought to enhance cholinergic function by increasing acetylcholine concentration through inhibition of its hydrolysis (US label 12.1).
- Rivastigmine: Reversible cholinesterase inhibitor; thought to enhance cholinergic function by increasing acetylcholine concentration through inhibition of its hydrolysis (US label 12.1).
أدوية ذات صلة
نفس المادة الفعالة بتركيز آخر
منتجات أخرى من Global Napi Pharmaceuticals
المصادر
- السعر: قوائم أسعار الأدوية المنشورة في مصر.
- DailyMed (U.S. National Library of Medicine)
- European Medicines Agency
تعليقات
لا توجد تعليقات بعد. كن أول من يشارك تجربته مع هذا الدواء.
أضف تعليقًا